New Key Statistics Module, Z-Score and F-Score
NAS:BDRX Key Ratios
| Market Cap $ M | 3.12 |
| Enterprise Value $ M | -2.92 |
| P/E(ttm) | 9,999.00 |
| PE Ratio without NRI | 9,999.00 |
| Forward PE Ratio | -- |
| Price/Book | 0.43 |
| Price/Sales | 42.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -75.97 |
| Beneish M-Score | 98.82 |
| 10-y EBITDA Growth Rate % | 42.10 |
| 5-y EBITDA Growth Rate % | 53.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.28 |
| EV-to-EBITDA | 0.29 |
| PEG | -- |
| Shares Outstanding M | 0.58 |
| Net Margin (%) | -8,215.66 |
| Operating Margin % | -9,630.12 |
| Pre-tax Margin (%) | -8,508.43 |
| Quick Ratio | 2.16 |
| Current Ratio | 2.16 |
| ROA % (ttm) | -63.00 |
| ROE % (ttm) | -109.37 |
| ROIC % (ttm) | -133.81 |
| Dividend Yield % | -- |
| Altman Z-Score | -20.97 |
BDRX Number of Guru Trades
BDRX Volume of Guru Trades
Gurus Latest Trades with NAS:BDRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BDRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biodexa Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:BDRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers